Richelieu Gestion’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$869K Sell
9,968
-12,517
-56% -$1.07M 0.89% 36
2023
Q4
$1.85M Sell
22,485
-9,417
-30% -$718K 1.66% 34
2023
Q3
$2.5M Sell
31,902
-14,272
-31% -$1.19M 2.32% 19
2023
Q2
$4.07M Buy
46,174
+2,731
+6% +$235K 3.39% 5
2023
Q1
$3.5M Buy
43,443
+411
+1% +$33.5K 3.16% 3
2022
Q4
$3.34M Buy
43,032
+5,592
+15% +$453K 3.5% 4
2022
Q3
$3.02M Sell
37,440
-889
-2% -$79.9K 3.6% 3
2022
Q2
$3.44M Sell
38,329
-10,504
-22% -$1.06M 3.9% 3
2022
Q1
$5.42M Buy
+48,833
New +$5.16M 4.31% 2

Other funds holding MDT

Richelieu Gestion's MDT Position: Q1 2024 in Review

Richelieu Gestion reduced its Medtronic (MDT) stake by 56% in Q1 2024, selling an estimated $1.07M and leaving 9,968 shares worth $869K. The position accounts for 0.89% of the portfolio, ranked #36.

Richelieu Gestion first reported a position in MDT in Q1 2022 and has held it in 9 quarters since. The position peaked at $5.42M in Q1 2022. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Richelieu Gestion held 9,968 shares of Medtronic worth $869K as of Q1 2024.
  • Richelieu Gestion sold 12,517 Medtronic shares in Q1 2024, an estimated $1.07M.
  • Medtronic made up 0.89% of Richelieu Gestion's portfolio in Q1 2024, its #36 holding.
  • Richelieu Gestion first reported a position in Medtronic in Q1 2022 and has held it in 9 quarters since.
  • Richelieu Gestion's Medtronic position peaked at $5.42M in Q1 2022.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Richelieu Gestion's 13F filing for Q1 2024, filed 15 Apr 2024.